64 related articles for article (PubMed ID: 35749312)
21. COVID-19 vaccine effectiveness against symptomatic SARS-CoV-2 infections, COVID-19 related hospitalizations and deaths, among individuals aged ≥65 years in Portugal: A cohort study based on data-linkage of national registries February-September 2021.
Machado A; Kislaya I; Rodrigues AP; Sequeira D; Lima J; Cruz C; Leite PP; Matias Dias C; Nunes B
PLoS One; 2022; 17(9):e0274008. PubMed ID: 36099273
[TBL] [Abstract][Full Text] [Related]
22. Celiac disease and Down syndrome mortality: a nationwide cohort study.
Ludvigsson JF; Lebwohl B; Green PH; Chung WK; Mårild K
BMC Pediatr; 2017 Jan; 17(1):41. PubMed ID: 28143429
[TBL] [Abstract][Full Text] [Related]
23. An international survey on the impact of COVID-19 in individuals with Down syndrome.
Hüls A; Costa ACS; Dierssen M; Baksh RA; Bargagna S; Baumer NT; Brandão AC; Carfi A; Carmona-Iragui M; Chicoine BA; Ghosh S; Lakhanpaul M; Manso C; Mayer MA; Del Carmen Ortega M; de Asua DR; Rebillat AS; Russell LA; Sgandurra G; Valentini D; Sherman SL; Strydom A
medRxiv; 2020 Nov; ():. PubMed ID: 33173907
[TBL] [Abstract][Full Text] [Related]
24. Late mortality and morbidity among long-term leukemia survivors with Down syndrome: A nationwide population-based cohort study.
Vonasek J; Asdahl P; Heyman M; Källén K; Hasle H
Pediatr Blood Cancer; 2018 Sep; 65(9):e27249. PubMed ID: 29797653
[TBL] [Abstract][Full Text] [Related]
25. Trends in survival among children with Down syndrome in 10 regions of the United States.
Kucik JE; Shin M; Siffel C; Marengo L; Correa A;
Pediatrics; 2013 Jan; 131(1):e27-36. PubMed ID: 23248222
[TBL] [Abstract][Full Text] [Related]
26. Risk of Major Cardiovascular Events in People with Down Syndrome.
Sobey CG; Judkins CP; Sundararajan V; Phan TG; Drummond GR; Srikanth VK
PLoS One; 2015; 10(9):e0137093. PubMed ID: 26421620
[TBL] [Abstract][Full Text] [Related]
27. Determinants and Effectiveness of BNT162b2 mRNA Vaccination Among Patients with Atopic Dermatitis: A Population-Based Study.
Kridin K; Schonmann Y; Onn E; Bitan DT; Weinstein O; Cohen AD
Am J Clin Dermatol; 2022 May; 23(3):385-392. PubMed ID: 35294720
[TBL] [Abstract][Full Text] [Related]
28. Association of BNT162b2 Vaccine Third Dose Receipt With Incidence of SARS-CoV-2 Infection, COVID-19-Related Hospitalization, and Death Among Residents of Long-term Care Facilities, August to October 2021.
Muhsen K; Maimon N; Mizrahi AY; Varticovschi B; Bodenheimer O; Cohen D; Dagan R
JAMA Netw Open; 2022 Jul; 5(7):e2219940. PubMed ID: 35796153
[TBL] [Abstract][Full Text] [Related]
29. Association Between Risk of COVID-19 Infection in Nonimmune Individuals and COVID-19 Immunity in Their Family Members.
Nordström P; Ballin M; Nordström A
JAMA Intern Med; 2021 Dec; 181(12):1589-1595. PubMed ID: 34633407
[TBL] [Abstract][Full Text] [Related]
30. The role of fetal growth restriction in the association between Down syndrome and perinatal mortality.
Yao R; Contag SA; Goetzinger KR; Crimmins SD; Kopelman JN; Turan S; Turan OM
J Matern Fetal Neonatal Med; 2020 Mar; 33(6):952-960. PubMed ID: 30196734
[No Abstract] [Full Text] [Related]
31. Causes of mortality among adults with Down syndrome before and after the COVID-19 pandemic in Spain.
Sánchez Moreno B; Adán-Lirola L; Rubio-Serrano J; Real de Asúa D
J Intellect Disabil Res; 2024 Feb; 68(2):128-139. PubMed ID: 37779228
[TBL] [Abstract][Full Text] [Related]
32. Retrospective review of the code status of individuals with Down syndrome during the COVID-19 era.
Jett J; Fossi A; Blonsky H; Ross W; Townsend S; Stephens MM; Chicoine B; Santoro SL
Am J Med Genet C Semin Med Genet; 2024 Mar; 196(1):e32080. PubMed ID: 38087874
[TBL] [Abstract][Full Text] [Related]
33. Down Syndrome patients with COVID-19 pneumonia: A high-risk category for unfavourable outcome.
Vita S; Di Bari V; Corpolongo A; Goletti D; Espinosa J; Petracca S; Palmieri F; Nicastri E;
Int J Infect Dis; 2021 Feb; 103():607-610. PubMed ID: 33271290
[TBL] [Abstract][Full Text] [Related]
34. Vaccine effectiveness against SARS-CoV-2 infection, hospitalization, and death when combining a first dose ChAdOx1 vaccine with a subsequent mRNA vaccine in Denmark: A nationwide population-based cohort study.
Gram MA; Nielsen J; Schelde AB; Nielsen KF; Moustsen-Helms IR; Sørensen AKB; Valentiner-Branth P; Emborg HD
PLoS Med; 2021 Dec; 18(12):e1003874. PubMed ID: 34919548
[TBL] [Abstract][Full Text] [Related]
35. SARS-CoV-2 vaccination, ABO blood group and risk of COVID-19: population-based cohort study.
Ray JG; Park AL
BMJ Open; 2022 Jul; 12(7):e059944. PubMed ID: 35851010
[TBL] [Abstract][Full Text] [Related]
36. Rate and severity of suspected SARS-Cov-2 reinfection in a cohort of PCR-positive COVID-19 patients.
Slezak J; Bruxvoort K; Fischer H; Broder B; Ackerson B; Tartof S
Clin Microbiol Infect; 2021 Dec; 27(12):1860.e7-1860.e10. PubMed ID: 34419576
[TBL] [Abstract][Full Text] [Related]
37. Down Syndrome and the Risk of Severe RSV Infection: A Meta-analysis.
Beckhaus AA; Castro-Rodriguez JA
Pediatrics; 2018 Sep; 142(3):. PubMed ID: 30093540
[TBL] [Abstract][Full Text] [Related]
38. Long-term sequelae in survivors of childhood leukemia with Down syndrome: A childhood cancer survivor study report.
Goldsby RE; Stratton KL; Raber S; Ablin A; Strong LC; Oeffinger K; Sklar CA; Armstrong GT; Robison LL; Bhatia S; Leisenring WM
Cancer; 2018 Feb; 124(3):617-625. PubMed ID: 29105081
[TBL] [Abstract][Full Text] [Related]
39. Sex differences for major congenital heart defects in Down Syndrome: A population based study.
Santoro M; Coi A; Spadoni I; Bianchi F; Pierini A
Eur J Med Genet; 2018 Sep; 61(9):546-550. PubMed ID: 29753092
[TBL] [Abstract][Full Text] [Related]
40. Weight status and associated comorbidities in children and adults with Down syndrome, autism spectrum disorder and intellectual and developmental disabilities.
Ptomey LT; Walpitage DL; Mohseni M; Dreyer Gillette ML; Davis AM; Forseth B; Dean EE; Waitman LR
J Intellect Disabil Res; 2020 Sep; 64(9):725-737. PubMed ID: 32716138
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
